Japan Intellectual Property Rights: DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS

Japan, July 1 -- PFIZER INC,ALLOGENE THERAPEUTICS INC has got intellectual property rights for 'DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS.' Other related details are as follows:

Application Number: JP,2024-208345

Category (FI): C12N15/864,100@Z,C07K19/00,C07K16/28,C07K14/705,C12N15/12,C12N15/13,C12N15/62@Z,C12N15/63@Z,C12N15/85@Z,C12N15/861@Z,C12N15/867@Z,C12N5/10,C12N5/0783,C12N5/0784,A61K39/395@N,A61K40/11,A61K40/15,A61K40/19,A61K40/31,A61K35/17,A61P11/00,A61P35/00,A61P37/04,C07K14/725

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Nov. 29, 2024

Publication Date: March 26, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.